NCT04911036

Brief Summary

This is an observational, national multicentre (34 centres involved), cross-sectional study in psychology whose objective is to describe and compare the levels of post-traumatic reactions of mothers to the announcement of their child's EA diagnosis. An ancillary study will be carried out among the fathers present who agree to participate in the study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
12mo left

Started May 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
May 2021May 2027

Study Start

First participant enrolled

May 6, 2021

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

May 27, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 2, 2021

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

6 years

First QC Date

May 27, 2021

Last Update Submit

December 17, 2025

Conditions

Keywords

Esophageal atresiapost-traumatic reactionsearly accompanimentPerinatal Posttraumatic Stress Disorder Questionnairecross-sectional study in psychology

Outcome Measures

Primary Outcomes (1)

  • Perinatal Posttraumatic Stress Disorder Questionnaire (score PPQ)

    The score PPQ derived from this instrument corresponds to the number of items (there are 14) to which the parent responded positively (theoretical spread: 0-14 points)

    at 2 months

Secondary Outcomes (4)

  • Percentage of mothers with Score PPQ >5

    at 2 months

  • Questionnaire on early support

    at 2 months

  • Correlation between STAI-Trait, Questionnaire on early support and Score PPQ evaluated to mothers

    at 2 months

  • Correlation between STAI-Trait, Questionnaire on early support and Score PPQ evaluated to fathers

    at 2 months

Study Arms (2)

Mothers and/or fathers with an antenatal diagnosis

Other: Questionnaires

Mothers and/or fathers with a postnatal diagnosis

Other: Questionnaires

Interventions

Perinatal PTSD Questionnaire State Trait Anxiety Inventory-forme Y-B Early Support Questionnaire Socio-demographic questionnaire

Mothers and/or fathers with a postnatal diagnosisMothers and/or fathers with an antenatal diagnosis

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsBe a mother and/or a father of a living child aged between 12 and 24 months who has undergone neonatal surgery following a diagnosis of type 1 or type 3 EA
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Be a mother and/or a father of a living child aged between 12 and 24 months who has undergone neonatal surgery following a diagnosis of type 1 or type 3 EA

You may qualify if:

  • Be the mother and/or a father of a living child aged 12 to 24 months who has undergone neonatal surgery following the diagnosis of type 1 or type 3 EA;
  • Not to have objected to participating in the study (information and non-objection form signed by the investigator);
  • To be socially insured.

You may not qualify if:

  • Woman or man whose child with AO has a chromosomal abnormality;
  • Woman or man whose child with AO has a polymalformative syndrome;
  • Female or male minor ;
  • Pregnant woman;
  • Woman or man who does not speak French;
  • Woman or man unable to consent, or benefiting from a legal protection regime (guardianship or curatorship);
  • Woman or man deprived of liberty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hop Jeanne de Flandre Chu Lille

Lille, 59037, France

RECRUITING

MeSH Terms

Conditions

Esophageal Atresia

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Digestive System AbnormalitiesDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Véronique Debarge, MD,PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Véronique Debarge, MD,PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2021

First Posted

June 2, 2021

Study Start

May 6, 2021

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

December 23, 2025

Record last verified: 2025-12

Locations